SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " rain " 7,535 found 🔀 AI-powered Shuffle
St. Mary’s woman doesn’t let brain injury stop her from business passion
Flourishing in Faith opened in a camper in 2020.
We turned 80-year-olds into trained health monitors to save lives and boost senior dignity
As a career geriatrician, I’ve long known that some of society’s finest minds are being underappreciated while living in senior communities. So I helped to develop a new health program to help put older adults on the watch as health monitors.
Seahawks Get Big Rashid Shaheed Update Ahead of Training Camp
The Seattle Seahawks have Jaxon Smith-Njigba as their WR1, but the question will be whether Rashid Shaheed can become a WR2. Last season, the Seahawks traded a fourth-round pick and a fifth-round pick in the 2026 NFL Draft to the New Orleans Saints for Shaheed. Moreover, Shaheed didn’t become a rental for the Seahawks, as […] The post Seahawks Get Big Rashid Shaheed Update Ahead of Training Camp appeared first on HEAVY.
Millions take omega-3 fish oil for brain health but a new study found no benefit
Fish oil supplements successfully delivered omega-3s to the brain, but a two-year study found no meaningful benefits for memory, cognition, or Alzheimer’s-related brain changes. The results challenge the idea that fish oil pills can help prevent Alzheimer’s and shift attention toward overall diet and lifestyle instead.
These fat-filled brain cells may be making multiple sclerosis worse
Scientists have uncovered a surprising clue that may help explain why multiple sclerosis (MS) progresses rapidly in some people but not others. In brain tissue from patients with severe MS, researchers found large numbers of “foamy” immune cells packed with fat droplets after absorbing damaged myelin. These overloaded cells appear to switch from helping repair the brain to fueling ongoing damage and inflammation.
Millions take omega-3 fish oil for brain health but a new study found no benefit
Fish oil supplements successfully delivered omega-3s to the brain, but a two-year study found no meaningful benefits for memory, cognition, or Alzheimer’s-related brain changes. The results challenge the idea that fish oil pills can help prevent Alzheimer’s and shift attention toward overall diet and lifestyle instead.
Texas Democrats leave convention united in effort to end GOP's 30-year hold on Texas
Texas Democrats spent their 3-day convention in Corpus Christi rallying party activists, training volunteers and making the case for Democratic policies and candidates across the state ahead of the 2026 midterm elections.
Brain activity under anesthesia challenges what we know about consciousness
The unconscious brain appears to be far more capable than scientists once believed. Researchers found that patients under general anesthesia could still process language at a sophisticated level, distinguishing nouns, verbs, and adjectives while listening to stories. Even more remarkably, neural activity showed signs of predicting upcoming words before they were heard. The results challenge traditional ideas about consciousness and hint at new possibilities for brain-computer interfaces.
Only one workout helped older adults lose fat without losing muscle
A six-month study of more than 120 adults in their 70s found that high-intensity interval training (HIIT) may offer a key advantage over other forms of exercise: it helped reduce body fat while preserving valuable muscle mass. While moderate and low-intensity workouts also led to some fat loss, only HIIT maintained lean muscle, which becomes increasingly important with age.
Common pesticide linked to more than double the risk of Parkinson’s disease
Scientists at UCLA have linked long-term exposure to the pesticide chlorpyrifos with a sharply increased risk of Parkinson’s disease. People exposed to the chemical near their homes were more than twice as likely to develop the condition. Laboratory studies showed that chlorpyrifos damages dopamine neurons and interferes with the brain’s ability to remove toxic protein buildup.
Only one workout helped older adults lose fat without losing muscle
A six-month study of more than 120 adults in their 70s found that high-intensity interval training (HIIT) may offer a key advantage over other forms of exercise: it helped reduce body fat while preserving valuable muscle mass. While moderate and low-intensity workouts also led to some fat loss, only HIIT maintained lean muscle, which becomes increasingly important with age.
Science & Medicine: Scanning the brain to improve treatment for traumatized teens
Around 20% of teens who have experienced emotional trauma don't respond to talk therapy. UT Health San Antonio is using neuroimaging to track brain changes in traumatized teens during a course of therapy to see if they can figure out why, which could lead to the development of more personalized treatments that will help more teens heal.
Shingles is linked to inflammation in the brain. Research shows how to cut dementia risk.
Shingles, a condition triggered by the reactivation of the varicella-zoster virus in the body, can cause a “war zone” of inflammation in the brain.
What watching a sunset can do for your brain
Humans appear to see sunrises and sunsets "almost like bookends". Here's what a daily dose of golden hour can do for our memory, sleep and mood.
Tuchel 'following Germany' but 'heart with the English team'
Thomas Tuchel wants to refrain from offering advice to the Germany national team during the World Cup while he works as England coach. "Of course I'm following the German team.
Alzheimer’s research headlines 2026 brain health summit
The summit, hosted by the University of Hawaii John A. Burns School of Medicine, highlighted the latest advances in Alzheimer’s research.
Dodgers getting stronger, planning to activate Teoscar Hernández
The Los Angeles outfielder has been on the IL since May 29 with a hamstring strain.
Florence community rallies for local business owner diagnosed with brain tumor, here’s how you can help
The Florence community held a fundraising event for a local business owner who was diagnosed with a brain tumor for the second time.
Alzheimer’s research headlines 2026 brain health summit
The event featured presentations on recent Alzheimer’s advancements.
Esports means business for new generation of fans
Valhallan, a youth esports training organization, hosted a grand reopening of its second Long Island storefront in Wantagh on Saturday.
See the fun at the 2026 Boone County Fair
See Kentucky residents embrace the rainy weather at the 2026 Boone County Fair. The fair also included a monster truck show.
The Simplest Focus Booster Is Sitting in Your Drawer Right Now
Science shows that writing by hand strengthens the brain by improving memory, focus, and deep thinking compared to typing.
Fidelio: Classical music meets politics
Vitali Alekseenok is passionate about classical music and politics. He is actively involved in Ukraine, advocates for a free Belarus, and conducts Beethoven's opera of freedom, 'Fidelio,' at the Deutsche Oper am Rhein.
Four participants join Coalition for Support of Ukrainian Science at URC 2026
Four participants—Estonia, Switzerland, the Swiss National Science Foundation, and the SaveScienceUA initiative—joined the International Coalition to Support Science, Research, and Innovation in Ukraine during the URC-2026 Conference in Gdańsk. — Ukrinform.
Andy Burnham distanced himself from UK Prime Minister Starmer, but may be stuck with his policies
Burnham, the former mayor of Greater Manchester who was sworn into Parliament hours after Starmer announced his resignation on Monday, will be constrained by the platform the center-left Labour Party was elected on that decisively ended 14 years of Conservative rule in 2024.
New vitamin B12 therapy shows promise against deadly brain cancer
Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor tissue and delivered sustained nitric oxide directly to cancer cells. It also worked synergistically with existing glioblastoma treatments, significantly enhancing their tumor-fighting effects.
Colts roster preview: AJ Haulcy garnering attention during offseason
With training camp off in the distance, we will be previewing each player on the Colts' 90-man roster. Up next is S AJ Haulcy.
Germany news: Heat soars as political reforms split opinion
As Europe's heatwave rages, Germany continues to swelter with new records expected Saturday. Elsewhere, politicians bicker over reforms and industry blames train operator DB for billions in losses. DW has the latest.
Lions announce 2026 training camp fan schedule, times
Here's when fans can catch the Detroit Lions during 2026 training camp.
The Best Diet For Brain Health Is Probably Not What You Think
There was one clear, standout winner.
Steelers’ Drew Allar Addresses Rookie Role Behind Aaron Rodgers
Pittsburgh Steelers quarterback Drew Allar spoke out on his place behind Aaron Rodgers on the team's depth chart entering 2026 NFL training camp. The post Steelers’ Drew Allar Addresses Rookie Role Behind Aaron Rodgers appeared first on HEAVY.
Just 2 Hours of Strength Training May Lower Heart Disease Risk in Women
Researchers say that just 2 hours of weekly strength training may help lower the risk of cardiovascular disease in women, especially when paired with 150 minutes of weekly aerobic exercise.
Businesses across Oahu prepare to close as rising costs strain operations
Community members say the closures are difficult to watch, especially as familiar businesses continue to disappear across the island.
Dolphins Training Camp Primer: Quarterbacks
A look at the Miami Dolphins' quarterbacks and where things may be headed during the 2026 season.
We almost had a smartphone in the 90s. Why did it fail?
In the early 90’s, a company called General Magic began working on a portable device that would allow people to check email, make phone calls, even play games. It was basically a smartphone. But it never caught on.On today’s show, a theory about why this device failed. General Magic had generous investors, world-class talent and creative freedom. But is it possible what they needed was constraints?Support:Planet Money+Read: Our book: Planet Money: A Guide to the Economic Forces That Shape Your Life Our weekly longform Planet Money newsletterOur weekly Indicator round-up newsletterFollow: InstagramTikTokYouTubeFacebookThis episode was hosted by Erika Beras and Emma Peaslee. It was produced by Emma Peaslee with help from Sam Yellowhorse Kesler and James Sneed. It was edited by Marianne McCune and fact-checked by Charlotte Isidore. It was engineered by Jimmy Keeley with help from Cena Loffredo. Alex Goldmark is Planet Money’s executive producer.
The 2x playback button on YouTube and TikTok is peak brainrot
My brain is so rotted from scrolling I can't watch anything on normal speeds.
Lorain flower shop celebrating 75 years as part of International Festival and Bazaar
Lorain has seen businesses come and go, but at least one has stood the test of time. Zelek Flower Shop celebrates 75 years this summer.
An Unexpected Vocation: Jaibir Nihal Singh’s Journey from Film Student to Business Executive
Though trained as a filmmaker at Pepperdine University’s Seaver College, Jaibir Nihal Singh found a way to leverage his creative skills into a career as a successful innovator. Now, as a member of Forbes 30 under 30, Singh credits his education as the launchpad for his vocation, even if he never saw it coming.
Texas Tech's Red Raider Meats Has Steak Down to a Science
The Lubbock university is training the next generation of agriculture scientists using revenue from selling some of the state's best beef
Science Can Fully Explain Consciousness? By 326 Theories…
It’s supposed to be a given that machines or brain organoids might be conscious despite not knowing what that is or how it works — but preborn children can’t be…
Scientists infected a 'vagina on a chip' with gonorrhea — then cured it with a new antibiotic found by AI
To sift through 6 million molecules in pursuit of new gonorrhea treatments, researchers trained AI to select the best drug candidate and then tested it in a "vagina on a chip."
New feed trailer expands feed delivery opportunities
Delivery of bulk feed produced at the Iowa State University Kent Feed Mill and Grain Science Complex to Iowa State’s animal science farms is now possible, thanks to a new high-tech feed trailer.
Early Homo sapiens may have lived in rainforests, new clues suggest — and it could overturn our understanding of human evolution
The long-held idea that rainforests held a minor role in our species' evolution is changing — and our ability to adapt to these tropical areas may give insight about 'what it means to be uniquely human.'
Andy Cohen cries as he mourns 28-year-old 'WWHL' producer who died of brain cancer
Andy Cohen became emotional mourning 'Watch What Happens Live' production manager Kyra Samson, 28, who died of brain cancer earlier this week.
Las Vegas group, school launch scholarship to expand access to skilled trades
The National Association of Women in Construction Las Vegas recently launched a new scholarship in partnership with trade school Quality Training Centers. The scholarship is intended to expose more...
Chaotic Push to Train Staff for US Ebola Outbreak Facility Alarms Health Workers
The three-day session focused more on administrative tasks than spread prevention.
New study suggests health damage from exposure to Ohio toxic train spill
Research finds immune systems still ‘responding to toxic chemical exposures’ related to East Palestine derailment
UNESCO places science and knowledge at the heart of recovery efforts
At the Ukraine Recovery Conference (URC) 2026, held in Gdańsk, Poland, on 25–26 June, UNESCO announced a new package of support of over EUR 2,5 million to help rebuild Ukraine’s scientific and
Sweden and WHO launch new long-term initiative to transform Ukraine’s health system
WHO and the Swedish International Development Cooperation Agency (Sida) have launched a new multi-year cooperation project to support the long-term recovery and transformation of Ukraine’s health system. The new project, “Ukraine’s Health System Transformation Initiative: Strengthening Health Governance, Health Financing and Service Delivery for Long-Term Recovery”, was launched at the Ukraine Recovery Conference 2026 in Gdansk, Poland on 26 June, and will run from June 2026 to 2029. Sweden will contribute approximately US$ 26 million (240 million Swedish krona) to support this project. This contribution forms part of Sweden’s broader support to Ukraine through the Team Europe approach, which brings together the European Union, its Member States, and key partners such as the European Commission’s Directorate-General for Enlargement and Eastern Neighbourhood and Enabel, and WHO as lead health agency, to support Ukraine’s recovery, reform agenda and European integration.“Ukraine’s health recovery cannot be measured only by what is rebuilt, but by whether people can count on the health system when they need it most. The scale of the task is immense, with health reconstruction and modernization needs estimated at US$ 19.4 billion over the next decade. Sweden’s US$ 26 million contribution to Ukraine’s Health System Transformation Initiative is a timely investment in the institutions, financing and services that will support Ukraine’s long-term recovery and European integration. WHO remains a trusted partner of the Government of Ukraine in advancing this process. I am deeply grateful to Sweden for its consistent support and partnership,” said Dr Hans Henri P. Kluge, WHO Regional Director for Europe. More than 4 years of war have placed unprecedented pressure on Ukraine’s health system, creating 3 interconnected challenges. The first is responding to the immediate consequences of the war and the urgent health needs of the population. The second is recovering and modernizing health services today. The third is continuing reforms and aligning the health system with European standards in the context of Ukraine’s future accession to the European Union. The war has led to large-scale population displacement, an increasing need for trauma care and rehabilitation, and shortages of health workers. High out-of-pocket payments in Ukraine make access to health services more difficult. Around 46% of total health expenditure is paid directly by individuals, placing a significant financial burden on many households and underscoring the need for reforms in health financing. Older people, persons with disabilities, women, children and veterans continue to face the greatest difficulties in accessing health services. “Ukraine is demonstrating that health system transformation can continue even during war. Ukraine is also continuing to align its health system with European norms and standards. WHO is committed to supporting Ukraine on this journey. We provide technical support, help coordinate partners’ efforts and support the institutional changes needed to strengthen the system. We are grateful to Sweden for its support. Through this partnership, we can help Ukraine build a more resilient, accessible and people-centred health system,” said Dr Jarno Habicht, WHO Representative in Ukraine. About the Health System Transformation InitiativeThe new initiative will support Ukraine through 3 interconnected areas: strengthening governance and coordination of health sector reforms through more inclusive coordination platforms and structured policy dialogue; transforming service delivery by reinforcing a primary health care-centred model that integrates family medicine, nursing and midwifery; and improving financial sustainability by supporting reforms that ensure the long-term viability of the national health system and reduce out-of-pocket payments for households. Overall, these reforms are expected to make the health system more coherent and easier to navigate, improve the quality and continuity of care, and ensure more equitable access to services, particularly for those who need them most. They will also support Ukraine’s progress towards a more modern health system aligned with European standards. “We are convinced that long-term recovery is not possible without strong, high-quality, person-centred health services that are accessible to everyone. Our partnership with WHO is designed to support deep and lasting systemic changes. Investments in human capital especially autonomous midwives, whose role for maternal, newborn and adolescent sexual and reproductive health cannot be understated, stronger governance, digital transformation and the financial sustainability of the health system are investments in Ukraine’s future. We are proud to support this process,” said Malin Perhult, the Head of the Ukraine Unit at Sida. Focus throughout implementation will be given to the most vulnerable population groups, including older people, women and children, and persons with disabilities, who have been affected by the war and face greater health-care needs. The initiative will be implemented in close cooperation with the Ministry of Health of Ukraine, the National Health Service of Ukraine, the Public Health Centre of Ukraine, regional authorities and international partners. This project will help Ukraine move towards a system where everyone can access the health care they need. It will strengthen primary care, make the health finance system more stable and predictable, and reduce the out-of-pocket costs that Ukrainians face when using health services. As a result, the Ukrainian health system will become more aligned with European standards and more sustainable in the long run.
Strength Training Could Be One of the Best Things You Do for Your Brain
A growing body of research suggests strength training can help preserve cognition and improve brain health as you age. Experts explain the best way to work strength training into your routine.
Trump forced to drain the reflecting pool swamp
Jonathan Freedland speaks to Arwa Mahdawi about why this project is proving to be such an embarrassing failure for the president
Ozone Ascent: Mega Rayquaza Timed Research
From Saturday, July 25, at 10:00 a.m. to Sunday, July 26, 2026, at 8:00 p.m. local time free Timed Research will be available to all Trainers that rewards a Meteorite that enables you to Mega Evolve Rayquaza! Complete the research tasks to earn a Meteorite, an encounter with Rayquaza, and more. Unlike other Mega-Evolving Pokémon, […]
Rain stopped play? Biggest worry now in British sport is extreme heat
Climate crisis is on show every day when sportspeople do their thing and the rest of us sweat on the sofa
The Big Summer Preview – New Starter Sets and ready painted terrain
Dive into Warhammer 40,000, and fight on the battlefields of Armageddon with new terrain kits.
Ex-NFL player Doug Martin's family sue Oakland police, allege restraint asphyxia in fatal mental health crisis
Parents of former NFL running back Doug Martin file wrongful death lawsuit alleging he died from restraint asphyxia caused by Oakland police.
Plaucheville business opens parking lot to Red Cross, polling site after flooding
One week after Avoyelles Parish received nearly 30 inches of rain in less than 12 hours, 2 Sisters’ Salsa is opening its parking lot to help the community recover.
Plaucheville business opens parking lot to Red Cross, polling site after flooding
One week after Avoyelles Parish received nearly 30 inches of rain in less than 12 hours, 2 Sisters’ Salsa is opening its parking lot to help the community recover.
Neuroimaging utilization in emergency departments has increased year-over-year for a decade
Researchers believe their new data could be used to better inform staffing coverage in modern radiology departments.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
PANAM SPORTS AND THE CANADIAN COACHES ASSOCIATION LAUNCH A CERTIFICATION PROGRAM FOR COACHES IN THE AMERICAS
With the goal of training and supporting the development of coaches on […]
Trump budget request omits funds for L.A. fire relief, prompting criticism from senators
The omission is the latest strain in a yearlong standoff between California leaders and the Trump administration over federal disaster aid.
Colts roster preview: Can Riley Leonard secure backup QB role?
With training camp off in the distance, we will be previewing each player on the Colts' 90-man roster. Up next is QB Riley Leonard.
Transcription by Ben Lerner wins Orwell prize for political fiction
Judging chair calls Lerner’s novel a ‘funny, brainy and timely’ study of our appetite for technology, while Karen Bartlett wins the nonfiction prize for The Escape from Kabul
Senate Democrats announce election observer program
The program will put trained, official observers on the ground to observe activities around polling places
Microsoft Discovery Aims To Advance The Era Of Agentic Science
The cloud-based agentic AI platform aims to help human researchers overcome resource constraints and complex data challenges to accelerate science at scale.
Employers Want AI-Enabled B-School Grads. But Do They Know What That Means?
A new survey of corporate recruiters says business schools need to focus on training students to use AI — in five years.
How Caesars’ Expanded Tribal iGaming and Community Partnership Could Shape Caesars Entertainment (CZR) Investors’ Outlook
In June 2026, Caesars Entertainment Inc. announced that it had expanded its partnership with three Wabanaki Nations in Maine to cover online casino gaming, aiming to launch Caesars Palace Online Casino, Caesars Sportsbook & Casino and Horseshoe Online Casino in 2026, subject to regulatory approval and integrated with Caesars Rewards and a universal digital wallet. A distinctive element of this agreement is Caesars’ commitment to employ and train tribal members while providing financial...
This weekend in Clarksville: Science guy, rodeo, Nunsense, ‘How to Train Your Dragon’
From science to fantasy, from rodeo to religion, there's a range of stuff going on in Clarksville this weekend.
$10 Million Gift to UAB Aims to Improve Rural Health Care Across Alabama
A $10 million gift to the University of Alabama at Birmingham will help train more primary care physicians in rural communities and encourage them to stay and p
The science of fatherhood from brain changes to ‘dad bod’
Darby Saxbe’s book combines academic data with ‘stories about the men in her own life’
Poor metabolic health can age the brain even in young people, finds new large-scale study
Two people of very different ages can have a similar level of biological aging in their brains. Such an occurrence is possible because aging and metabolic health follow two distinct pathways that influence ...
Gilbert-backed Cosm gets $100M Sony investment as immersive theater operator expands to Detroit
A Cosm location in downtown Detroit is expected to open in September as part of Dan Gilbert’s Bedrock LLC real estate firm’s Development at Cadillac Square project.
Scientists discover how a single cell builds a brain with 170 billion cells
How does a single cell build a brain with billions of precisely organized neurons? Researchers suggest that brain cells use their lineage—their cellular family tree—as a kind of positional map. Cells that come from the same ancestor stay near one another, helping the brain organize itself without relying solely on chemical signals.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Playing soccer can score major goals for heart and brain health
Seattle, June 25, 2026 — As the global soccer championship run by the Fédération Internationale de Football Association (FIFA) plays out on stages across the world this summer, catching a fever for football (as soccer is known outside the U.S.) may...
The Heart-Healthy Way to Lift Weights, Explained by a Doctor
In TODAY.com’s Expert Tip of the Day, a sports medicine doctor reveals whether it’s better to use heavier weights with fewer reps or lighter weights with more reps for a healthy heart.
Science with Stevie: Making your own rain gauge
Meteorologist Stevie Daniels shows kids how to become weather scientists with a fun summer experiment that measures rainfall from seasonal storms.
Jaguars roster: Where does DeeJay Dallas fit in backfield?
DeeJay Dallas enters training camp looking to carve out a role in the Jaguars' crowded backfield, with special teams likely playing a key part.
The Science Behind World Cup Performance: Inside Oklahoma State's Human Performance Lab
As the world's best soccer players compete at the FIFA World Cup, teams are relying on more than coaches and training sessions to gain an edge.Behind the scenes
Milwaukee County judge weighs in on rising mental health felony cases
Investigative reporting found that mental competency evaluations in felony cases have roughly doubled since 2013, straining resources for the state criminal justice system.
Highlights of Aspen Ideas: Health, day two
On June 23, Aspen Ideas: Health ushered in the actual first full day — and evening — of programming. Here are some highlights from different tracks, or themes. NextGen Health Track: On the Frontiers of Brain Health “As belly size gets larger, the memory center in the brain gets smaller,” said Richard Isaacson, director...
Think 8 Hours of Sleep Is the Best for Your Cognitive Health? A New Study Suggests Otherwise
Research reveals a hidden genetic link that dictates exactly how your nighttime routine impacts your brain.
Giant viruses discovered on Greenland ice sheet may slow glacial melting - Futura-Sciences
Giant viruses defy microbiological norms Lead author Laura Perini and her team at the Department of Environmental Science at Aarhus University identified the microorganisms during a field survey of Arctic ice. Measuring up to 2.5 micrometers in length, these viral specimens are roughly 125 times larger than conventional viral strains....
Dallas Cowboys 2026 training camp schedule released
We officially have a Dallas Cowboys training camp schedule.
Colts insider identifies potential 'surprise' starter on defense
One Colts insider identified a potential "surprise" starter on defense who could emerge during training camp.
Akron Children's launches new mental health tool
The goal is to combine real human connection from trained well-being coaches with AI tools, the hospital said.
5 foods that contain both protein and fiber
With these sweet-spot foods you get both the protein perks, like muscle maintenance, and the fiber perks, like improved gut health and reduced risks of chronic conditions, all in one bite.
Scientists finally explain what your dog's eyes do to your brain - Futura-Sciences
That soft look your dog gives you across the room feels like love, and it turns out that is not just sentimental projection. When you and your dog lock eyes, both of your brains release the same bonding hormone that ties a mother to her newborn. Scientists have measured it,...
Scientists discover ancient brain cells that help block distractions
Scientists have discovered a tiny group of neurons in an ancient brain region that acts like a built-in focus filter, helping the brain ignore distractions and zero in on what matters most. When researchers temporarily switched off these neurons in mice, the animals became unusually distractible—similar to what is seen in ADHD—but regained normal focus as soon as the neurons were reactivated.
Financing the Future: Leaders Make the Investment Case for Women's, Children's and Adolescents' Health
With development assistance declining and health systems under growing strain, leaders at Africa Health ExCon called for a shift from fragmented financing to integrated, sustainable investment in women’s, children’s and adolescents’ health. Discussions highlighted domestic financing, private sector engagement, service integration and climate-resilient health systems as pathways to greater impact.
Service meets science: Meet the first graduate of UAB’s Master of Science in AI in Medicine
UAB’s first graduate of the M.S. in AI in Medicine program blends clinical training with artificial intelligence, highlighting how physicians can use AI to reduce burnout, improve patient care and shape the future of healthcare.
The universe may be hiding conscious minds stranger than we can imagine
What if consciousness isn’t limited to brains like ours? Philosophers Eric Schwitzgebel and Jeremy Pober argue that consciousness could arise in many different forms of life, even in beings built from radically different materials than those found on Earth. Drawing on the vastness of the universe and the likely existence of countless alien civilizations, they suggest it would be surprisingly Earth-centric to assume that only Earth-like biology can support conscious experience.
Science in Seconds: Improving GLP-1
A UConn Health researcher explains how her lab is focusing on how GLP-1 medications affect the brain and how they can be improved for the future
Whole Health Institute looks to grow residencies
Many Arkansas-trained physicians leave the state for their residency, lowering the odds they return to practice here.
Best Prime Day Pokémon deals 2026: Chaos Rising Elite Trainer Box on sale
TCGplayer and Walmart are competing for the best deals.
'Rangers close to re-signing McCrorie'
Rangers are closing in on a deal to bring 28-year-old versatile Scotland-capped defender Ross McCrorie back to Ibrox from Bristol City. Rangers Review) Rangers are preparing to submit a formal offer for 22-year-old Dundee centre-back Luke Graham in the coming weeks. Football Insider) Head coach Steven Pressley says Dundee have received "plenty of phone calls" about Luke Graham this summer, but there has been no firm offers for the centre-half who trained with the senior Scotland squad before the World Cup.